Aeglea BioTherapeutics
program overview | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
February 2022
Slide
21 of 33
Related slides by other companies
BioAtla
Investor Presentation
August 2023
focused pipeline with broad applicability of differentiated cab assets designed to deliver near term value | BioAtla
Larimar Therapeutics
Investor Presentation
October 2022
phase clinical program in patients with | Larimar Therapeutics
BioAtla
Investor Presentation
November 2022
focused pipeline with broad applicability of differentiated cab assets designed to deliver near term value pay a venoms dosing ease dosing | BioAtla
ATAI
Investor Presentation
January 2024
program status phase expected in clinical trial design results | ATAI
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io